241 related articles for article (PubMed ID: 6879640)
1. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
Gorsky JE; Latts JR
Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
[TBL] [Abstract][Full Text] [Related]
2. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
Buchanan AG; Witwicki E; Albritton WL
Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
[TBL] [Abstract][Full Text] [Related]
3. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
Dzierzanowska D; Nowik-Jurek M; Podleśny J
Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
[TBL] [Abstract][Full Text] [Related]
4. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
[TBL] [Abstract][Full Text] [Related]
5. Prospective audit of an aminoglycoside consultative service in a general hospital.
Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
8. Determining aminoglycoside dosage and blood levels using a programmable calculator.
Ng PK
Am J Hosp Pharm; 1980 Feb; 37(2):225-31. PubMed ID: 7361795
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside monitoring program.
Vakoutis J; Stein GE; Miller PB; Clayman AE
Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
[TBL] [Abstract][Full Text] [Related]
10. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monitoring as an aid in rationalizing aminoglycoside dosage techniques in the neonate.
Spruyt LL; Kirsten GF; Parkin DP; Müller GJ; Kriegler A
S Afr Med J; 1987 Oct; 72(7):463-5. PubMed ID: 3660149
[TBL] [Abstract][Full Text] [Related]
12. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
Ohler KH; Menke JA; Fuller L
Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
[TBL] [Abstract][Full Text] [Related]
13. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
[TBL] [Abstract][Full Text] [Related]
14. Effect of time and temperature on inactivation of aminoglycosides by ampicillin at neonatal dosages.
Daly JS; Dodge RA; Glew RH; Keroack MA; Bednarek FJ; Whalen M
J Perinatol; 1997; 17(1):42-5. PubMed ID: 9069064
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of an aminoglycoside monitoring service.
Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
[TBL] [Abstract][Full Text] [Related]
16. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Prescott WA
Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
[TBL] [Abstract][Full Text] [Related]
17. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
Prins JM; Weverling GJ; van Ketel RJ; Speelman P
Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
[TBL] [Abstract][Full Text] [Related]
18. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
Weibert R; Keane W; Shapiro F
Trans Am Soc Artif Intern Organs; 1976; 22():439-43. PubMed ID: 951863
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
[TBL] [Abstract][Full Text] [Related]
20. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital.
Bollish SJ; Kelly WN; Miller DE; Timmons RG
Am J Hosp Pharm; 1981 Jan; 38(1):73-6. PubMed ID: 7211873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
